Clinical Trial Update: A Study of Telitacicept in Lupus Nephritis [Phase 2]

View source ↗

Summary

Phase 2 study of Telitacicept for lupus nephritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Telitacicept

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Lupus Nephritis | Phase 2 | Status: RECRUITING